Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
R-5780 is an innovative, orally administered immune oncology drug candidate developed by RISE Therapeutics LLC. It is designed to activate gut-regulated immune pathways, enhancing the effectiveness of immune checkpoint inhibitors in cancer treatment. It represents a pioneering approach in leveraging synthetic biology to engage selective immune pathways, supporting a robust anti-tumor T-cell response.
Company information 2025-03-21
…